The largest database of trusted experimental protocols

Cdk2 mrna 3 utr mutant

Manufactured by GenePharma
Sourced in China

CDK2 mRNA 3'UTR mutant is a lab equipment product that allows for the study of the 3' untranslated region (3'UTR) of the CDK2 gene. The 3'UTR plays a role in the regulation of gene expression. This product can be used to investigate the impact of mutations in the CDK2 mRNA 3'UTR.

Automatically generated - may contain errors

4 protocols using cdk2 mrna 3 utr mutant

1

Validation of miR-1179 Binding Sites

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oligonucleotides comprising the circ_0084927 mutant (the sequence containing the miR-1179 binding site was mutated to GAUACGA) or the CDK2 mRNA 3′UTR mutant (the sequence containing the miR-1179 binding site was mutated to GAUACGA) were synthesized by GenePharma (Shanghai, China). Inserted into the dual-luciferase miRNA target expression vector (pGL4) were wild-type circ_0084927, circ_0084927 mutant, CDK2 3′UTR mutant, and wild-type CDK2 3′UTR. This insertion was performed to construct luciferase reporter plasmid. HeLa and C-33A cells were also co-transfected with luciferase porter plasmid and miR-1179 mimic. After 48 h of incubation, the culture medium was removed to collect the cells. The collected cells were then lysed to obtain cell lysates. The luciferase activity was measured by Pierce Renilla-Firefly Luciferase Dual Assay Kit (16185; Thermo Fisher Scientific, Inc., Waltham, MA, USA) according to the protocol.
+ Open protocol
+ Expand
2

Regulation of circ_0084927 and CDK2 by miR-1179

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oligonucleotides comprising the circ_0084927 mutant (the sequence containing the miR-1179 binding site was mutated to GAUACGA) or the CDK2 mRNA 3'UTR mutant (the sequence containing the miR-1179 binding site was mutated to GAUACGA) were synthesized by GenePharma (Shanghai, China). circ_0084927 wild type, circ_0084927 mutant, CDK2 3′UTR mutant and CDK2 wild-type were inserted into the Dual-Luciferase miRNA target expression vector (pGL4) to construct luciferase reporter plasmid. HeLa and C-33A cells were co-transfected with luciferase porter plasmid and miR-1179 mimic. After 48 hours of incubation, the culture medium was removed to collect the cells. The collected cells were lysed to collect cell lysates. The luciferase activity was measured by Pierce Renilla-Fire y Luciferase Dual Assay Kit (16185; Thermo Fisher Scienti c, Inc., Waltham, MA, USA) according to the protocol.
+ Open protocol
+ Expand
3

Validation of miR-1179 Binding Site Mutations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oligonucleotides comprising the circ_0084927 mutant (the sequence containing the miR-1179 binding site was mutated to GAUACGA) or the CDK2 mRNA 3'UTR mutant (the sequence containing the miR-1179 binding site was mutated to GAUACGA) were synthesized by GenePharma (Shanghai, China). Inserted into the dual-luciferase miRNA target expression vector (pGL4) were wild-type circ_0084927, circ_0084927 mutant, CDK2 3′UTR mutant, and wild-type CDK2 3'UTR. This insertion was performed to construct luciferase reporter plasmid. HeLa and C-33A cells were also co-transfected with luciferase porter plasmid and miR-1179 mimic. After 48 hours of incubation, the culture medium was removed to collect the cells. The collected cells were then lysed to obtain cell lysates. The luciferase activity was measured by Pierce Renilla-Fire y Luciferase Dual Assay Kit (16185; Thermo Fisher Scienti c, Inc., Waltham, MA, USA) according to the protocol.
+ Open protocol
+ Expand
4

Regulation of circ_0084927 and CDK2 by miR-1179

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oligonucleotides comprising the circ_0084927 mutant (the sequence containing the miR-1179 binding site was mutated to GAUACGA) or the CDK2 mRNA 3'UTR mutant (the sequence containing the miR-1179 binding site was mutated to GAUACGA) were synthesized by GenePharma (Shanghai, China). circ_0084927 wild type, circ_0084927 mutant, CDK2 3′UTR mutant and CDK2 wild-type were inserted into the Dual-Luciferase miRNA target expression vector (pGL4) to construct luciferase reporter plasmid. HeLa and C-33A cells were co-transfected with luciferase porter plasmid and miR-1179 mimic. After 48 hours of incubation, the culture medium was removed to collect the cells. The collected cells were lysed to collect cell lysates. The luciferase activity was measured by Pierce Renilla-Fire y Luciferase Dual Assay Kit (16185; Thermo Fisher Scienti c, Inc., Waltham, MA, USA) according to the protocol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!